Publications
Discover how our technologies have been applied
Our technologies and bioinformatics workflows have been used to obtain deep insights into different aspects of RNA biology, and our own scientific team frequently publishes on our newest capabilities. The following publications provide some examples of how our partners have utilized our capabilities to make groundbreaking discoveries. Contact us today to learn how we can help you achieve your therapeutic and research goals.
Contact usThe RNA m6A binding protein YTHDF2 promotes the B cell to plasma cell transition.
Turner et al. bioRxiv
miR-486 is an epigenetic modulator of Duchenne muscular dystrophy pathologies.
Hightower et al. bioRxiv
Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition.
Inoue et al. Nature Genetics
Activation of Gαq sequesters specific transcripts into Ago2 particles.
Jackson, et al. Scientific Reports
Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation.
Wang et al. Cell Stem Cell
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.
Bieging-Rolett et al. Molecular Cell